Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine -- Ignore unavailable to you. Want to Upgrade?

To: Rick Strange who wrote (251)	1/30/1998 9:48:00 AM
From: andy harrison	Read Replies (1) \| Respond to of 507

Rick: From what I understand on this matter, you are totally wrong. The other accellular DTaP (excluding NVX) use pieces of the killed cell of the pertussis bacteria to stimulate the immuned response. NVX is the only one that uses a highly purified concentrated toxoid to produce the immune response. THe idea of using the toxoid (NVX) was used in order to eliminate the major side effects. As a matter of fact, this was the biggest controversy before the trials started whether a toxoid could stimulate sufficient immune response and now we see it can.

To: Rick Strange who wrote (251)	1/30/1998 10:18:00 AM
From: Don W Stone	Read Replies (1) \| Respond to of 507

Rick Strange:You said: <<<<<You are reading conclussions into Dr Schellekens statements that are not supported by fact. You say:"Dr Schellekens says the multipomponent vaccines may cause a smaller or later epidemic." He never said that and it is a leap of fantasy to draw such a conclussion. >>>>> Rick, You are letting your commitment to being SHORT in NVX get in the way of your even being able to read a Reuters news release correctly. Go back and read the next to last statement which is a direct quote from Dr. Schellekens. Now as to your specific question I think you need to do your own homework. The fact that you ask such a question does indeed explain to me why you are shorting NVX. You really don't know anything about CERTIVA. By the way ORG has an inbalance of trades here at the opening , indications are it is going to open between 25 to 30. That is fantastic. :-} My understanding is that ORG and NVX are the two stocks that Sturza loves to hate. Barrons/ Abelson got took big time once again. "When the shorts are in trouble they do make noise." ORG would open a lot higher but the big shorts are in there fighting for their life and shorting the hell out of it.